Telehealth platform Hims & Hers will begin offering a generic version of liraglutide, a GLP-1 weight loss drug, to its customers in 2025, Quartz reported Nov. 4.

The millennial-skewed telehealth platform Hims & Hers (HIMS) announced Monday that it will start offering customers a generic ...

While plenty of people rave about the weight loss results you can get from drugs like Ozempic, there’s also been a ton of ...

Poorer folks' access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found. Only 13 ...

Wegovy® is the only version of semaglutide that is FDA-approved for weight loss, while Ozempic® and other forms of the drug ...

Collaborative telehealth platform will provide patients with immediate access to QSYMIA®, a chronic weight loss medication, enhancing their ...

GLP-1 medications, including semaglutide, have been recognized for their role in supporting weight loss through the regulation of blood sugar levels and appetite control. Studies have shown that these ...

Cost of revenue increased by $4.7 million, or 69 percent, in fiscal 2024, mainly due to a 70 percent increase in the number of telemedicine cases compared to fiscal 2023. Cash used in operating ...

MangoRx remains committed to its mission and plans to continue to enhance patient care by offering new and innovative ...

No. 24 Michigan dropped to 4-3 on Saturday with a 21-7 loss to No. 22 Illinois, becoming the second reigning national champion in the last 30 years to lose three of its first seven games the ...

He assured Global News he is forthright about his medical conditions, including high blood pressure, and has previously informed the insurer that he takes two prescription medications. But when he ...